06:28 AM EDT, 08/22/2025 (MT Newswires) -- Natera ( NTRA ) said Friday it has launched its proprietary AI foundation model platform, which is designed to accelerate therapeutic development.

Results from the first pilot showed that its algorithm can accurately recommend immunotherapy based on real-world electronic health record data.

The company also said that the second pilot showed outperformance of both tumor mutational burden and standalone pathology-based metrics in predicting immunotherapy response.